Diabetes and Healthy Liver- Unravelling the links between postprandial metabolism in type 2 diabetes and progression of metabolic fatty liver disease.

糖尿病和健康肝脏 - 揭示 2 型糖尿病的餐后代谢与代谢性脂肪肝疾病进展之间的联系。

• 批准号: 452995
• 负责人: Carreau Anne-Marie
• 金额: $ 52.67万
• 依托单位: CHU de Qubec
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2026-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=452995&lang=en
• 关键词: Diabetes; Fatty Liver Disease; Glucose Metabolism; Insulin Clearance; Insulin Resistance; Insulin Secretion; Lipid Metabolism; Mitochondrial Function; Tca Cycle; Diabetes; Fatty Liver Disease; Glucose Metabolism; Insulin Clearance; Insulin Resistance; Insulin Secretion; Lipid Metabolism; Mitochondrial Function; Tca Cycle

An accumulation of fat in the liver can lead to inflammation, which can be very severe in some people, and can even lead to cirrhosis. This disease is called fatty liver disease. In recent years, researchers have identified type 2 diabetes as the largest

肝脏中脂肪的积累会导致炎症，在某些人中可能非常严重，甚至可能导致肝硬化。这种疾病称为脂肪肝病。近年来，研究人员将2型糖尿病确定为最大的糖尿病